Blood test may predict insulin need in pregnancy diabetes

NCT ID NCT02159378

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether measuring fructosamine levels in the blood can help predict which women with gestational diabetes will need insulin. Researchers enrolled 200 pregnant women and measured their fructosamine levels. The goal was to see if this test could guide treatment decisions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Fructosamines (blood test)

What this could lead to

If successful, this could help doctors predict which women with gestational diabetes will need insulin, allowing earlier treatment.

What could go wrong

This is a small, completed observational study, not a treatment trial. Fructosamine is not a proven predictor, and results may not change practice.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PREGNANCY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

gestational diabetes

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Centre hospitalier départemental Vendée

    La Roche-sur-Yon, 85925, France